License fees include periodic milestone payments, research and development contract fees and the amortization of upfront payments received from licensing partners. Merck KGaA’s subsidiary Merck Serono ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Cetrorelix (Cetrotide) is an injectable ...
AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, announces that it has completed the transaction under the previously ...
AEterna Zentaris Inc. (Nasdaq: AEZS) has agreed to sell Cowen Healthcare Royalty Partners its rights to royalties on future sales of Cetrotide, covered by AEterna’s license agreement with Merck Serono ...
Cetrotide, a drug commonly used by women undergoing in vitro fertilization, will not be available in parts of Europe because of an unidentified production issue with its manufacturer, Merck KGaA. The ...
QUÉBEC CITY, Oct. 1, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the successful completion of its previously announced agreements with various ...
AEterna Zentaris (AEZS) Agrees to Sell Cetrotide Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners Quebec City, Canada, November 12, 2008 - Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: ...
Aeterna Zentaris’ German subsidiary transferred manufacturing rights and granted a manufacturing license for Cetrotide® to Merck Serono. The deal is expected to be finalized on or about October 1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results